• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATX 4.13% 5.8¢

AMPLIA THERAPEUTICS LIMITED - Announcements

Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development... Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development company. The Company is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. The Company’s pipeline includes AMP945 and AMP886. AMP945 is a selective and potent inhibitor of FAK and is in clinical development for pancreatic cancer and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The Company’s second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its fibrosis program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue and therefore block survival/proliferation signals.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


ATX Amplia Appoints New Non-Executive Director12/04/21 download Created with Sketch. 104.72KB
ATX Change of Registered Office and Principal Place of Business25/03/21 download Created with Sketch. 122.95KB
ATX Appendix 2A - Exercise of Options24/03/21 download Created with Sketch. 417.24KB
ATX Amplia and Garvan Institute Enter Collaboration AgreementPRICE SENSITIVE18/03/21 download Created with Sketch. 109.54KB
ATX Amplia Completes Single Dose Study of AMP945PRICE SENSITIVE17/03/21 download Created with Sketch. 102.66KB
ATX Amplia Initiates Multiple Dose Study of AMP945PRICE SENSITIVE17/02/21 download Created with Sketch. 105.52KB
ATX Appendix 2A - Exercise of Options16/02/21 download Created with Sketch. 417.1KB
ATX Investor Update - February 2021PRICE SENSITIVE11/02/21 download Created with Sketch. 1.9MB
ATX Quarterly Activities and Cashflow Reports - Dec 2020 QtrPRICE SENSITIVE28/01/21 download Created with Sketch. 246.63KB
ATX Appendix 2A - Exercise of Options11/01/21 download Created with Sketch. 270.74KB
ATX Shareholder Update - 2020 Review17/12/20 download Created with Sketch. 1.09MB
ATX Amplia Receives $0.53m R&D Tax IncentivePRICE SENSITIVE02/12/20 download Created with Sketch. 104.44KB
ATX Appendix 4D and Financial Report Half Year Ended 30 Sep 2020PRICE SENSITIVE27/11/20 download Created with Sketch. 828.49KB
ATX Appendix 2A - Allot Shares upon Exercise of Options24/11/20 download Created with Sketch. 272.39KB
ATX Notice ASX LR 3.11.2 - Change of Exercise Price of Options02/11/20 download Created with Sketch. 105.8KB
ATX ATX - Sep 2020 Quarter Activities and Cashflow ReportsPRICE SENSITIVE29/10/20 download Created with Sketch. 165.5KB
ATX Amplia Presentation to Reach Market Services - Meet the CEO21/10/20 download Created with Sketch. 3.22MB
ATX Response to ASX Price QueryPRICE SENSITIVE20/10/20 download Created with Sketch. 205.56KB
ATX First Human Dose in Phase 1 Clinical Trial of AMP945PRICE SENSITIVE08/10/20 download Created with Sketch. 105.87KB
ATX Change of Director's Interest Notice - Dr. Warwick Tong18/09/20 download Created with Sketch. 239.4KB
ATX Change of Director's Interest Notice - Dr. Robert Peach18/09/20 download Created with Sketch. 240.94KB
ATX Change of Director's Interest Notice - Dr. C. Burns18/09/20 download Created with Sketch. 236.24KB
ATX Section 708A Cleansing Notice - Allotment of Shares18/09/20 download Created with Sketch. 106.08KB
ATX Appendix 2A - Application for Quotation of Shares18/09/20 download Created with Sketch. 267KB
ATX Results of Annual General Meeting18/09/20 download Created with Sketch. 140.17KB
ATX CEO Presentation to AGM18/09/20 download Created with Sketch. 1.63MB
ATX Amplia Receives Ethics Clearance fo Conduct Phase 1 TrialPRICE SENSITIVE08/09/20 download Created with Sketch. 108KB
ATX Appendix 3G - Notification of Issue of Securities - Options02/09/20 download Created with Sketch. 243.9KB
ATX Amplia Appoints Dr Mark Devlin as Chief Scientific Officer31/08/20 download Created with Sketch. 107.74KB
ATX Notice of Annual General Meeting & Proxy - YE 31 March 202017/08/20 download Created with Sketch. 717.14KB
ATX Change in substantial holding06/08/20 download Created with Sketch. 223.74KB
ATX Change in substantial holding06/08/20 download Created with Sketch. 138.98KB
ATX Change of Director Interest - Dr Lambert - Entitlement Offer05/08/20 download Created with Sketch. 244.24KB
ATX Change of Directors Interest - Dr W Tong - Entitlement Offer05/08/20 download Created with Sketch. 237.6KB
ATX Appendix 2A - Retail Entitlement Offer04/08/20 download Created with Sketch. 266.45KB
ATX Appendix 4G - Key to Corporate Governance Disclosures31/07/20 download Created with Sketch. 230.56KB
ATX 2020 Corporate Governance Statement31/07/20 download Created with Sketch. 216.71KB
ATX Annual Report to Shareholders - YE 31 March 202031/07/20 download Created with Sketch. 1.05MB
ATX Entitlement Offer CompletedPRICE SENSITIVE30/07/20 download Created with Sketch. 106.98KB
ATX Quarterly Activities and Cashflow Reports - June 2020PRICE SENSITIVE27/07/20 download Created with Sketch. 219.1KB
ATX Nucleus Network Appointed to Conduct Phase 1 Clinical TrialPRICE SENSITIVE23/07/20 download Created with Sketch. 104.82KB
ATX AGM to be held Friday 18 September 202020/07/20 download Created with Sketch. 101.65KB
ATX Change of Director's Interest Notice - Dr. Warwick Tong14/07/20 download Created with Sketch. 168.55KB
ATX Becoming a substantial holder14/07/20 download Created with Sketch. 279.37KB
ATX Becoming a substantial holder14/07/20 download Created with Sketch. 267.31KB
ATX Change in substantial holding14/07/20 download Created with Sketch. 141.82KB
ATX Appendix 2A - Institutional Entitlement Offer10/07/20 download Created with Sketch. 166.44KB
ATX Entitlement Offer - Despatch of Retail Offer Booklet08/07/20 download Created with Sketch. 2.22MB
ATX Institutional Entitlement Offer CompletedPRICE SENSITIVE03/07/20 download Created with Sketch. 109.29KB
ATX Appendix 3B - Rights Issue01/07/20 download Created with Sketch. 548.04KB
ATX Entitlement Offer Cleansing Notice01/07/20 download Created with Sketch. 82.1KB
ATX Capital Raising - Investor PresentationPRICE SENSITIVE01/07/20 download Created with Sketch. 3.63MB
ATX Entitlement Offer to Fund Phase 1 Clinical TrialPRICE SENSITIVE01/07/20 download Created with Sketch. 226.49KB
ATX Trading HaltPRICE SENSITIVE01/07/20 download Created with Sketch. 481.97KB
ATX Pause in TradingPRICE SENSITIVE01/07/20 download Created with Sketch. 115.53KB
ATX Preliminary Toxicology Studies Support Phase1 Clinical TrialPRICE SENSITIVE30/06/20 download Created with Sketch. 105.32KB
ATX Trading HaltPRICE SENSITIVE29/06/20 download Created with Sketch. 134.89KB
ATX Full Year Statutory Accounts - YE 31 March 202025/06/20 download Created with Sketch. 1.2MB
ATX Investor Presentation02/06/20 download Created with Sketch. 4.99MB
ATX Preliminary Final Report - YE 31 March 2020PRICE SENSITIVE29/05/20 download Created with Sketch. 226.35KB
ATX FDA Orphan Drug Designation - Idiopathic Pulmonary FibrosisPRICE SENSITIVE19/05/20 download Created with Sketch. 113.17KB
ATX Quarterly Activities Report - March 2020 QtrPRICE SENSITIVE28/04/20 download Created with Sketch. 114.28KB
ATX App 4C - Quarterly Cash Flow Report - March 2020 QtrPRICE SENSITIVE28/04/20 download Created with Sketch. 163.85KB
ATX Shares to be Released from Voluntary Escrow07/04/20 download Created with Sketch. 99.76KB
ATX FDA Awards Orphan Drug Designation for Pancreatic CancerPRICE SENSITIVE25/03/20 download Created with Sketch. 103.05KB
ATX Professor Paul Timpson Joins Amplia's SAB13/02/20 download Created with Sketch. 108.42KB
ATX Initial Director's Interest Notice - John Lambert12/02/20 download Created with Sketch. 232.56KB
ATX Final Director's Interest Notice - Behrenbruch07/02/20 download Created with Sketch. 198.95KB
ATX Final Director's Interest Notice - Wilkinson07/02/20 download Created with Sketch. 220.69KB
ATX Final Director's Interest Notice - Cooke07/02/20 download Created with Sketch. 197.49KB
ATX Dr. John Lambert appointed as Managing DirectorPRICE SENSITIVE06/02/20 download Created with Sketch. 100.02KB
ATX Board Restructuring06/02/20 download Created with Sketch. 107.08KB
ATX Placement Cleasing Statement30/01/20 download Created with Sketch. 105.89KB
ATX Appendix 4C Cash Flow - Dec 2019 QtrPRICE SENSITIVE30/01/20 download Created with Sketch. 179.52KB
ATX Ceasing to be a substantial holder - Behrenbruch28/01/20 download Created with Sketch. 90.48KB
ATX Becoming a substantial holder28/01/20 download Created with Sketch. 196.96KB
ATX Appendix 3B - Placement24/01/20 download Created with Sketch. 232.72KB
ATX Amplia Therapeutics Undertakes PlacementPRICE SENSITIVE20/01/20 download Created with Sketch. 102.62KB
ATX Trading HaltPRICE SENSITIVE16/01/20 download Created with Sketch. 180.43KB
ATX Change of Registered Office and Principal Place of Business18/12/19 download Created with Sketch. 98.99KB
ATX Shareholder Update / 2019 Review17/12/19 download Created with Sketch. 9.52MB
ATX App 4D - Financial Report Half Year Ended 30 Sep 2019PRICE SENSITIVE29/11/19 download Created with Sketch. 658.67KB
ATX App 4C - Sep 2019 Qtr Cash Flows StatementPRICE SENSITIVE01/11/19 download Created with Sketch. 77.92KB
ATX Becoming a substantial holder01/11/19 download Created with Sketch. 109.46KB
ATX Ceasing to be a substantial holder01/11/19 download Created with Sketch. 79.45KB
ATX Change of Director's Interest - Dr Robert Peach - Placement17/09/19 download Created with Sketch. 135.03KB
ATX Change of Director's Interest - Dr C Behrenbruch - Placement17/09/19 download Created with Sketch. 131.96KB
ATX Change of Director's Interest - Dr Warwick Tong, Placement17/09/19 download Created with Sketch. 133.07KB
ATX Placement Cleansing Notice17/09/19 download Created with Sketch. 107.79KB
ATX App 3B Placement Shares and Options to Directors and Mgt17/09/19 download Created with Sketch. 231.16KB
ATX Amplia Therapeutics Provides Manufacturing Update02/09/19 download Created with Sketch. 114.13KB
ATX Results of Annual General Meeting30/08/19 download Created with Sketch. 139.52KB
ATX Change of Director's Interest - S Wilkinson - Options Lapsed21/08/19 download Created with Sketch. 130.44KB
ATX Amplia Therapeutics - Quarterly Update12/08/19 download Created with Sketch. 291.29KB
ATX Change of Director's Interest - Dr Warwick Tong Rights Issue05/08/19 download Created with Sketch. 131.85KB
ATX Change of Director's Interest - Dr Chris Burns, Rights Issue05/08/19 download Created with Sketch. 131.18KB
ATX Change of Director's Interest - Andrew Cooke, Rights Issue05/08/19 download Created with Sketch. 132.97KB
ATX Appendix 4C - Quarterly Cash Flow Report - June 2019 QtrPRICE SENSITIVE31/07/19 download Created with Sketch. 191.95KB
ATX RightsIssue Participation Supports Clinical-Enabling StudiesPRICE SENSITIVE31/07/19 download Created with Sketch. 106.94KB
ATX Amplia Therapeutics - Bioshares Presentation July 201925/07/19 download Created with Sketch. 1.18MB
ATX Amplia Appoints New Non-Executive Director
12/04/21 download Created with Sketch. 104.72KB
ATX Change of Registered Office and Principal Place of Business
25/03/21 download Created with Sketch. 122.95KB
ATX Appendix 2A - Exercise of Options
24/03/21 download Created with Sketch. 417.24KB
ATX Amplia and Garvan Institute Enter Collaboration Agreement
18/03/21PRICE SENSITIVE download Created with Sketch. 109.54KB
ATX Amplia Completes Single Dose Study of AMP945
17/03/21PRICE SENSITIVE download Created with Sketch. 102.66KB
ATX Amplia Initiates Multiple Dose Study of AMP945
17/02/21PRICE SENSITIVE download Created with Sketch. 105.52KB
ATX Appendix 2A - Exercise of Options
16/02/21 download Created with Sketch. 417.1KB
ATX Investor Update - February 2021
11/02/21PRICE SENSITIVE download Created with Sketch. 1.9MB
ATX Quarterly Activities and Cashflow Reports - Dec 2020 Qtr
28/01/21PRICE SENSITIVE download Created with Sketch. 246.63KB
ATX Appendix 2A - Exercise of Options
11/01/21 download Created with Sketch. 270.74KB
ATX Shareholder Update - 2020 Review
17/12/20 download Created with Sketch. 1.09MB
ATX Amplia Receives $0.53m R&D Tax Incentive
02/12/20PRICE SENSITIVE download Created with Sketch. 104.44KB
ATX Appendix 4D and Financial Report Half Year Ended 30 Sep 2020
27/11/20PRICE SENSITIVE download Created with Sketch. 828.49KB
ATX Appendix 2A - Allot Shares upon Exercise of Options
24/11/20 download Created with Sketch. 272.39KB
ATX Notice ASX LR 3.11.2 - Change of Exercise Price of Options
02/11/20 download Created with Sketch. 105.8KB
ATX ATX - Sep 2020 Quarter Activities and Cashflow Reports
29/10/20PRICE SENSITIVE download Created with Sketch. 165.5KB
ATX Amplia Presentation to Reach Market Services - Meet the CEO
21/10/20 download Created with Sketch. 3.22MB
ATX Response to ASX Price Query
20/10/20PRICE SENSITIVE download Created with Sketch. 205.56KB
ATX First Human Dose in Phase 1 Clinical Trial of AMP945
08/10/20PRICE SENSITIVE download Created with Sketch. 105.87KB
ATX Change of Director's Interest Notice - Dr. Warwick Tong
18/09/20 download Created with Sketch. 239.4KB
ATX Change of Director's Interest Notice - Dr. Robert Peach
18/09/20 download Created with Sketch. 240.94KB
ATX Change of Director's Interest Notice - Dr. C. Burns
18/09/20 download Created with Sketch. 236.24KB
ATX Section 708A Cleansing Notice - Allotment of Shares
18/09/20 download Created with Sketch. 106.08KB
ATX Appendix 2A - Application for Quotation of Shares
18/09/20 download Created with Sketch. 267KB
ATX Results of Annual General Meeting
18/09/20 download Created with Sketch. 140.17KB
ATX CEO Presentation to AGM
18/09/20 download Created with Sketch. 1.63MB
ATX Amplia Receives Ethics Clearance fo Conduct Phase 1 Trial
08/09/20PRICE SENSITIVE download Created with Sketch. 108KB
ATX Appendix 3G - Notification of Issue of Securities - Options
02/09/20 download Created with Sketch. 243.9KB
ATX Amplia Appoints Dr Mark Devlin as Chief Scientific Officer
31/08/20 download Created with Sketch. 107.74KB
ATX Notice of Annual General Meeting & Proxy - YE 31 March 2020
17/08/20 download Created with Sketch. 717.14KB
ATX Change in substantial holding
06/08/20 download Created with Sketch. 223.74KB
ATX Change in substantial holding
06/08/20 download Created with Sketch. 138.98KB
ATX Change of Director Interest - Dr Lambert - Entitlement Offer
05/08/20 download Created with Sketch. 244.24KB
ATX Change of Directors Interest - Dr W Tong - Entitlement Offer
05/08/20 download Created with Sketch. 237.6KB
ATX Appendix 2A - Retail Entitlement Offer
04/08/20 download Created with Sketch. 266.45KB
ATX Appendix 4G - Key to Corporate Governance Disclosures
31/07/20 download Created with Sketch. 230.56KB
ATX 2020 Corporate Governance Statement
31/07/20 download Created with Sketch. 216.71KB
ATX Annual Report to Shareholders - YE 31 March 2020
31/07/20 download Created with Sketch. 1.05MB
ATX Entitlement Offer Completed
30/07/20PRICE SENSITIVE download Created with Sketch. 106.98KB
ATX Quarterly Activities and Cashflow Reports - June 2020
27/07/20PRICE SENSITIVE download Created with Sketch. 219.1KB
ATX Nucleus Network Appointed to Conduct Phase 1 Clinical Trial
23/07/20PRICE SENSITIVE download Created with Sketch. 104.82KB
ATX AGM to be held Friday 18 September 2020
20/07/20 download Created with Sketch. 101.65KB
ATX Change of Director's Interest Notice - Dr. Warwick Tong
14/07/20 download Created with Sketch. 168.55KB
ATX Becoming a substantial holder
14/07/20 download Created with Sketch. 279.37KB
ATX Becoming a substantial holder
14/07/20 download Created with Sketch. 267.31KB
ATX Change in substantial holding
14/07/20 download Created with Sketch. 141.82KB
ATX Appendix 2A - Institutional Entitlement Offer
10/07/20 download Created with Sketch. 166.44KB
ATX Entitlement Offer - Despatch of Retail Offer Booklet
08/07/20 download Created with Sketch. 2.22MB
ATX Institutional Entitlement Offer Completed
03/07/20PRICE SENSITIVE download Created with Sketch. 109.29KB
ATX Appendix 3B - Rights Issue
01/07/20 download Created with Sketch. 548.04KB
ATX Entitlement Offer Cleansing Notice
01/07/20 download Created with Sketch. 82.1KB
ATX Capital Raising - Investor Presentation
01/07/20PRICE SENSITIVE download Created with Sketch. 3.63MB
ATX Entitlement Offer to Fund Phase 1 Clinical Trial
01/07/20PRICE SENSITIVE download Created with Sketch. 226.49KB
ATX Trading Halt
01/07/20PRICE SENSITIVE download Created with Sketch. 481.97KB
ATX Pause in Trading
01/07/20PRICE SENSITIVE download Created with Sketch. 115.53KB
ATX Preliminary Toxicology Studies Support Phase1 Clinical Trial
30/06/20PRICE SENSITIVE download Created with Sketch. 105.32KB
ATX Trading Halt
29/06/20PRICE SENSITIVE download Created with Sketch. 134.89KB
ATX Full Year Statutory Accounts - YE 31 March 2020
25/06/20 download Created with Sketch. 1.2MB
ATX Investor Presentation
02/06/20 download Created with Sketch. 4.99MB
ATX Preliminary Final Report - YE 31 March 2020
29/05/20PRICE SENSITIVE download Created with Sketch. 226.35KB
ATX FDA Orphan Drug Designation - Idiopathic Pulmonary Fibrosis
19/05/20PRICE SENSITIVE download Created with Sketch. 113.17KB
ATX Quarterly Activities Report - March 2020 Qtr
28/04/20PRICE SENSITIVE download Created with Sketch. 114.28KB
ATX App 4C - Quarterly Cash Flow Report - March 2020 Qtr
28/04/20PRICE SENSITIVE download Created with Sketch. 163.85KB
ATX Shares to be Released from Voluntary Escrow
07/04/20 download Created with Sketch. 99.76KB
ATX FDA Awards Orphan Drug Designation for Pancreatic Cancer
25/03/20PRICE SENSITIVE download Created with Sketch. 103.05KB
ATX Professor Paul Timpson Joins Amplia's SAB
13/02/20 download Created with Sketch. 108.42KB
ATX Initial Director's Interest Notice - John Lambert
12/02/20 download Created with Sketch. 232.56KB
ATX Final Director's Interest Notice - Behrenbruch
07/02/20 download Created with Sketch. 198.95KB
ATX Final Director's Interest Notice - Wilkinson
07/02/20 download Created with Sketch. 220.69KB
ATX Final Director's Interest Notice - Cooke
07/02/20 download Created with Sketch. 197.49KB
ATX Dr. John Lambert appointed as Managing Director
06/02/20PRICE SENSITIVE download Created with Sketch. 100.02KB
ATX Board Restructuring
06/02/20 download Created with Sketch. 107.08KB
ATX Placement Cleasing Statement
30/01/20 download Created with Sketch. 105.89KB
ATX Appendix 4C Cash Flow - Dec 2019 Qtr
30/01/20PRICE SENSITIVE download Created with Sketch. 179.52KB
ATX Ceasing to be a substantial holder - Behrenbruch
28/01/20 download Created with Sketch. 90.48KB
ATX Becoming a substantial holder
28/01/20 download Created with Sketch. 196.96KB
ATX Appendix 3B - Placement
24/01/20 download Created with Sketch. 232.72KB
ATX Amplia Therapeutics Undertakes Placement
20/01/20PRICE SENSITIVE download Created with Sketch. 102.62KB
ATX Trading Halt
16/01/20PRICE SENSITIVE download Created with Sketch. 180.43KB
ATX Change of Registered Office and Principal Place of Business
18/12/19 download Created with Sketch. 98.99KB
ATX Shareholder Update / 2019 Review
17/12/19 download Created with Sketch. 9.52MB
ATX App 4D - Financial Report Half Year Ended 30 Sep 2019
29/11/19PRICE SENSITIVE download Created with Sketch. 658.67KB
ATX App 4C - Sep 2019 Qtr Cash Flows Statement
01/11/19PRICE SENSITIVE download Created with Sketch. 77.92KB
ATX Becoming a substantial holder
01/11/19 download Created with Sketch. 109.46KB
ATX Ceasing to be a substantial holder
01/11/19 download Created with Sketch. 79.45KB
ATX Change of Director's Interest - Dr Robert Peach - Placement
17/09/19 download Created with Sketch. 135.03KB
ATX Change of Director's Interest - Dr C Behrenbruch - Placement
17/09/19 download Created with Sketch. 131.96KB
ATX Change of Director's Interest - Dr Warwick Tong, Placement
17/09/19 download Created with Sketch. 133.07KB
ATX Placement Cleansing Notice
17/09/19 download Created with Sketch. 107.79KB
ATX App 3B Placement Shares and Options to Directors and Mgt
17/09/19 download Created with Sketch. 231.16KB
ATX Amplia Therapeutics Provides Manufacturing Update
02/09/19 download Created with Sketch. 114.13KB
ATX Results of Annual General Meeting
30/08/19 download Created with Sketch. 139.52KB
ATX Change of Director's Interest - S Wilkinson - Options Lapsed
21/08/19 download Created with Sketch. 130.44KB
ATX Amplia Therapeutics - Quarterly Update
12/08/19 download Created with Sketch. 291.29KB
ATX Change of Director's Interest - Dr Warwick Tong Rights Issue
05/08/19 download Created with Sketch. 131.85KB
ATX Change of Director's Interest - Dr Chris Burns, Rights Issue
05/08/19 download Created with Sketch. 131.18KB
ATX Change of Director's Interest - Andrew Cooke, Rights Issue
05/08/19 download Created with Sketch. 132.97KB
ATX Appendix 4C - Quarterly Cash Flow Report - June 2019 Qtr
31/07/19PRICE SENSITIVE download Created with Sketch. 191.95KB
ATX RightsIssue Participation Supports Clinical-Enabling Studies
31/07/19PRICE SENSITIVE download Created with Sketch. 106.94KB
ATX Amplia Therapeutics - Bioshares Presentation July 2019
25/07/19 download Created with Sketch. 1.18MB
(20min delay)
Last
5.8¢
Change
-0.003(4.13%)
Mkt cap ! $15.75M
Open High Low Value Volume
5.9¢ 6.1¢ 5.8¢ $30.32K 507.3K

Buyers (Bids)

No. Vol. Price($)
2 57229 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.1¢ 100000 1
View Market Depth
Last trade - 16.10pm 17/05/2024 (20 minute delay) ?
Last
6.1¢
  Change
-0.003 ( 0.00 %)
Open High Low Volume
6.0¢ 6.1¢ 5.9¢ 360164
Last updated 14.41pm 17/05/2024 ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.